SURROZEN INC SRZN

US Healthcare Biological Products, (No Diagnostic Substances)
$24.92
-2.4%
52w: $8.29 – $34.13

Latest 13F among current holders filed 37 days ago (May 29, 2026)

Price — last 12 months

research preview data
8.2921.2134.13
Jun 20, 2025 Jul 2, 2026
Institutional holders
58
+4 QoQ
13F value
$275.3M
+76.2% QoQ
Smart-money holders
18
signal tier ≥ 2
New smart buyers
3
Q1 2026
Options barometer
calls only
$2.7M calls / — puts

Institutional value by quarter

$9.3M
Q1 2024
$16.2M
Q2 2024
$15.8M
Q3 2024
$23.8M
Q4 2024
$46.0M
Q1 2025
$41.7M
Q2 2025
$64.1M
Q3 2025
$156.3M
Q4 2025
$275.3M
Q1 2026

Number of holders

16
Q1 2024
21
Q2 2024
23
Q3 2024
24
Q4 2024
30
Q1 2025
31
Q2 2025
35
Q3 2025
54
Q4 2025
58
Q1 2026

Who owns SRZN?

Q1 2026 filings
FundTypeSharesValue% of fundChange
TCG Crossover Management, LLC ★3Fundamental concentrated1.5M$42.9M1.2%New
Kalehua Capital Management LLC ★2Fundamental concentrated770.4K$22.4M8.6%+100.0%
Boxer Capital Management, LLC ★2Fundamental concentrated766.3K$22.3M2.9%+84.1%
MILLENNIUM MANAGEMENT LLC Multistrat pod731.1K$21.3M0.0%+1.4%
STEMPOINT CAPITAL LP ★2Fundamental concentrated721.6K$19.2M1.9%+16.4%
Venrock Adviser, LLC ★3Fundamental concentrated632.9K$18.4M0.7%Held
Spruce Street Capital LP ★2Fundamental concentrated432.0K$12.6M3.0%Held
BRAIDWELL LP ★2Fundamental diversified396.1K$11.5M0.4%-15.7%
5AM Venture Management, LLC ★3Fundamental concentrated387.5K$11.3M3.1%Held
Vestal Point Capital, LP ★2Fundamental diversified338.6K$9.9M0.3%New
Vivo Capital, LLC ★3Fundamental concentrated260.0K$7.6M0.6%Held
PERCEPTIVE ADVISORS LLC ★2Fundamental diversified229.4K$6.7M0.1%New
Woodline Partners LP Other227.8K$6.6M0.0%-1.2%
Balyasny Asset Management L.P. Multistrat pod203.9K$5.9M0.0%+7.0%
Ikarian Capital, LLC ★2Fundamental diversified173.1K$5.0M0.7%+163.1%
ACUTA CAPITAL PARTNERS, LLC ★2Fundamental concentrated172.8K$5.0M3.6%-3.1%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical169.1K$4.9M0.0%
AMERIPRISE FINANCIAL INC Bank broker159.7K$4.7M0.0%+143.1%
SILVERARC CAPITAL MANAGEMENT, LLC ★2Fundamental diversified144.3K$4.2M0.5%-8.3%
REGENTS OF THE UNIVERSITY OF CALIFORNIA ★2Fundamental concentrated133.2K$3.9M0.1%-50.0%
ADAGE CAPITAL PARTNERS GP, L.L.C. Other88.7K$2.6M0.0%Held
Euclidean Capital LLC Wealth advisor87.7K$2.6M0.7%Held
FRED ALGER MANAGEMENT, LLC Other71.7K$2.1M0.0%-28.0%
GEODE CAPITAL MANAGEMENT, LLC Index provider65.8K$1.9M0.0%-1.7%
Eversept Partners, LP ★2Fundamental diversified58.6K$1.7M0.1%-38.5%
ArrowMark Colorado Holdings LLC Other55.1K$1.6M0.0%Held
RENAISSANCE TECHNOLOGIES LLC Quant stat arb49.1K$1.4M0.0%+117.1%
BOOTHBAY FUND MANAGEMENT, LLC Diversified mechanical47.3K$1.4M0.0%+158.4%
TWO SIGMA INVESTMENTS, LP Quant stat arb39.5K$1.2M0.0%New
CITADEL ADVISORS LLC Multistrat pod35.5K$1.0M0.0%+140.6%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical35.4K$1.0M0.0%
Stonepine Capital Management, LLC ★2Fundamental concentrated33.0K$961K0.8%-71.0%
683 Capital Management, LLC ★2Fundamental diversified33.0K$961K0.1%-21.4%
BlackRock, Inc. Index provider27.9K$811K0.0%+6.6%
STATE STREET CORP Index provider27.7K$808K0.0%+14.0%
GOLDMAN SACHS GROUP INC Bank broker25.9K$753K0.0%+0.1%
LMR Partners LLP Quant stat arb23.6K$686K0.0%Held
MORGAN STANLEY Bank broker22.4K$654K0.0%-39.3%
PRICE T ROWE ASSOCIATES INC /MD/ Diversified mechanical21.7K$633K0.0%Held
UBS Group AG Bank broker21.2K$619K0.0%+35911.9%
MARSHALL WACE, LLP Quant stat arb18.9K$551K0.0%+73.1%
Qube Research & Technologies Ltd Quant stat arb14.5K$423K0.0%New
NORTHERN TRUST CORP Index provider12.3K$357K0.0%-9.3%
HRT FINANCIAL LP Diversified mechanical12.2K$354K0.0%New
ADAR1 Capital Management, LLC Other12.0K$350K0.0%New
Alyeska Investment Group, L.P. Quant stat arb10.2K$297K0.0%Held
Hudson Bay Capital Management LP Multistrat pod8.7K$252K0.0%New
BNP PARIBAS FINANCIAL MARKETS Bank broker7.3K$213K0.0%+190.7%
Persistent Asset Partners Ltd Quant stat arb7.1K$208K0.1%+63.9%
JANE STREET GROUP, LLC Market maker7.1K$207K0.0%-74.3%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.